Clinical Trial Update: Axatilimab for Sclerotic Chronic Graft-versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Axatilimab in sclerotic chronic graft-versus-host disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: RECRUITING